OsteoarthitisNCT07107412
Turkish General Rehabilitation Adherence Scale in Osteoarthritis Patients
An observational study of Osteoarthitis, run by KTO Karatay University at 1 site in Turkey (Türkiye).
Trial summary
Investigation of the Turkish Validity and Reliability of The General Rehabilitation Adherence Scale in Osteoarthritis Patients Read more about this study
- Who is it for?
- Ages 18 to 85 years
- Conditions the study is for
- Osteoarthitis
- What is being tested?
- Translating the Questionnaire into Turkish and Related Processes
- How many people
- 88 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Aug 2025to 4 Nov 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Individuals with osteoarthritis
Who may be able to join
- To be diagnosed with osteoarthritis
- To be receiving physiotherapy
- Age between 18-85
Who cannot join
- Patients who do not want to participate
- Patients who filled out the questionnaire incompletely
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Turkish Validity and Reliability of The General Rehabilitation Adherence Scale in Osteoarthritis Patients
Investigation of the Turkish Validity and Reliability of The General Rehabilitation Adherence Scale in Osteoarthritis Patients
- Conditions
- Osteoarthitis
- Being tested
- Translating the Questionnaire into Turkish and Related Processes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Translating the Questionnaire into Turkish and Related ProcessesOther
The first step is the translation from the original language to the other language. The ideal target in the translation phase is to use people who are familiar with the structure of the original language and who are familiar with the language. Two forward translation and one reverse translation methods will be applied after obtaining the written permission of the authors. After the completion of this phase, the terminological differences arising from the translators in the translation process from the original language to Turkish will be collected and discussed on the questions. The cultural adaptation study will be terminated by determining the equivalence between the Turkish version of the index and the English original. The final version of the questionnaire and the necessary changes will be arranged specific to the investigator's society and the authors of the original questionnaire will be consulted and the questionnaire will be finalized.
Other: Validity The scale will be applied
What is being measured
The primary outcome is the main question the study is designed to answer.
Validity
The scale will be applied by face-to-face technique and convergent (moderate-high correlation with optimism measure) and distant (low correlation with depression and anxiety measures) validity will be evaluated.
Measured: Baseline
Reliability
The reliability of the materials will be tested with Cronbach alpha.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2025
- Study start1 Aug 2025
- Primary completion1 Nov 2025
- Study completion4 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for OsteoarthitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 88 participants (actual)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hasan Gerçek, KTO Karatay University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07107412
- Sponsor's protocol ID
- KaratayUH15
- Status last verified
- Nov 2025
- First submitted
- 30 Jul 2025
- Last updated
- 20 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Gercek H, Ozturk S, Cakir F, Dursun B, Torlak MS, Celik F, Unuvar BS, Aytar A. Validity and reliability of the Turkish version of the general rehabilitation adherence scale in individuals with osteoarthritis. BMC Musculoskelet Disord. 2026 May 21;27(1):620. doi: 10.1186/s12891-026-09922-7.
PubMed 42163199
Study at a glance
From the registry record, last updated by the sponsor on 20 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Turkish Validity and Reliability of The General Rehabilitation Adherence Scale in Osteoarthritis Patients
- ClinicalTrials.gov ID
- NCT07107412
- Acronym / sponsor ID
- KaratayUH15
- Conditions
- Osteoarthitis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 88 participants (actual)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Study start
- 1 Aug 2025 (actual)
- Primary completion
- 1 Nov 2025 (actual)
- Study completion
- 4 Nov 2025 (actual)
- First posted
- 6 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigation of the Turkish Validity and Reliability of The General Rehabilitation Adherence Scale in Osteoarthritis Patients
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Individuals with osteoarthritis
Key inclusion criteria (3 listed)
- To be diagnosed with osteoarthritis
- To be receiving physiotherapy
- Age between 18-85
Key exclusion criteria (2 listed)
- Patients who do not want to participate
- Patients who filled out the questionnaire incompletely
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Translating the Questionnaire into Turkish and Related ProcessesThe first step is the translation from the original language to the other language. The ideal target in the translation phase is to use people who are familiar with the structure of the original language and who are familiar with the language. Two forward translation and one reverse translation methods will be applied after obtaining the written permission of the authors. After the completion of this phase, the terminological differences arising from the translators in the translation process from the original language to Turkish will be collected and discussed on the questions. The cultural adaptation study will be terminated by determining the equivalence between the Turkish version of the index and the English original. The final version of the questionnaire and the necessary changes will be arranged specific to the investigator's society and the authors of the original questionnaire will be consulted and the questionnaire will be finalized. Other: Validity The scale will be applied | Other | – |
Primary outcome
Validity
Time frame: Baseline
The scale will be applied by face-to-face technique and convergent (moderate-high correlation with optimism measure) and distant (low correlation with depression and anxiety measures) validity will be evaluated.
Reliability
Time frame: Baseline
The reliability of the materials will be tested with Cronbach alpha.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Nov 2025.
- Derived from this study: PubMed 42163199Gercek H, Ozturk S, Cakir F, Dursun B, Torlak MS, Celik F, Unuvar BS, Aytar A. Validity and reliability of the Turkish version of the general rehabilitation adherence scale in individuals with osteoarthritis. BMC Musculoskelet Disord. 2026 May 21;27(1):620. doi: 10.1186/s12891-026-09922-7.
- Individual participant dataSharing planned: Undecided
Related trials for Osteoarthitis
Recruiting
Low Dose Radiotherapy for Osteoarthritis
Osteoarthitis
Recruiting
Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection
Osteoarthitis, Osteoarthritic Knee Pain
Recruiting
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent Pain in Patients With Severe Knee Osteoarthritis
Osteoarthitis
Not yet recruitingPhase 2
CBD Knee Osteoarthritis Study
Osteoarthitis
Not yet recruitingObservational study
Biomechanical Evaluation With Finite Element Models in Thumb Carpometacarpal Osteoarthitis: Prospective Comparative Analysis of Loads in Arthroplasty With or Without Implants
Thumb Carpometacarpal Joint Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarthitis, run by KTO Karatay University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Validity (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07107412, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2025.